PMCB vs AAPL: Which Stock is Better?
Side-by-side comparison of PharmaCyte Biotech Inc and Apple Inc in 2026
PMCB
PharmaCyte Biotech Inc
$0.49
AAPL
Apple Inc
$325.13
Key Metrics Comparison
| Metric | PMCB | AAPL | Winner |
|---|---|---|---|
| Market Cap | $8.59M | $3.83T | AAPL |
| P/E Ratio | N/A | 34.84 | AAPL |
| EPS (TTM) | $N/A | $7.47 | AAPL |
| Revenue Growth | 0.0% | 7.9% | AAPL |
| Gross Margin | 0.0% | 46.9% | AAPL |
Analyze PMCB
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PMCB or AAPL a better investment?
Comparing PMCB and AAPL: PharmaCyte Biotech Inc has a market cap of $8.59M while Apple Inc has $3.83T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PMCB and AAPL?
PMCB (PharmaCyte Biotech Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PMCB or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: PMCB or AAPL?
AAPL has higher revenue growth at 7.9% vs 0.0% for PMCB.
Which company is more profitable: PMCB or AAPL?
Apple Inc (AAPL) has higher gross margins at 46.9% compared to 0.0% for PMCB.
Which is the larger company: PMCB or AAPL?
Apple Inc (AAPL) is larger with a market cap of $3.83T compared to $8.59M for PMCB.
Should I buy PMCB or AAPL in 2026?
Both PMCB and AAPL have investment merit. PMCB trades at $0.49 while AAPL trades at $325.13. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PMCB and AAPL stock?
Key differences: Market Cap ($8.59M vs $3.83T), P/E Ratio (N/A vs 34.8x), Revenue Growth (0.0% vs 7.9%), Gross Margin (0.0% vs 46.9%).
Should I buy PMCB or AAPL in 2026?
The choice between PMCB and AAPL depends on your investment goals. AAPL shows higher revenue growth (7.9%). AAPL has better margins (46.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between PMCB and AAPL?
PMCB (PharmaCyte Biotech Inc) has a market cap of $8.59M, while AAPL (Apple Inc) has a market cap of $3.83T. AAPL is the larger company by market value.